VISA ATLASWork visas & talent mobility
From→ToFind a corridor EN
☰

Celltrans Inc

Employer · Illinois, United States

Employer address
Illinois, United States
Applications on record
7
FY2025 applications
0
FY2026 to 30 June
0
Programmes
LCA
Median offered wage
$47,258
Most common occupation
Medical Scientists, Except Epidemiologists
Year by year
Data as at 30 Jun 2026
VE<USACELLTRANS<INC<<<<<<<<<<<<<<<<<<<<<<<<<
IL76<FY20179<FY2026Q32<<<<<<<<<<<<<<<<<<<<<6

Applications year by year

Celltrans Inc appears in 7 applications filed with the U.S. Department of Labor between fiscal 2017 and fiscal 2026 (to 30 June).

Applications by fiscal year — Celltrans Inc

23FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026*
23FY2017FY2019FY2021FY2023FY2025FY2026*
Data table
FY20173
FY20182
FY20190
FY20200
FY20212
FY20220
FY20230
FY20240
FY20250
FY2026*0
Fiscal yearLCA
FY2026*0
FY20250
FY20240
FY20230
FY20220
FY20212
FY20200
FY20190
FY20182
FY20173
Source: U.S. Department of Labor, Office of Foreign Labor Certification — disclosure data FY2008–FY2026 Q3Data as at 30 Jun 2026

Where the jobs are

Worksite of each application as filed (first worksite where several are listed).

Celltrans Inc: applications by worksite state

7+7+7+7+7+
7+7+7+7+7+
Data table
StateApplications
IL7
Worksite states
  1. Illinois7
Worksite cities
  1. Chicago, IL7
Source: U.S. Department of Labor, Office of Foreign Labor Certification — disclosure data FY2008–FY2026 Q3Data as at 30 Jun 2026

What they hire for and pay

Occupations, job titles and offered wages as stated on the applications.

Occupations (SOC 2018)
  1. Medical Scientists, Except Epidemiologists7
Job titles on labor condition applications
  1. Research Scientist3
  2. Senior Research and Manufacturing Associate2
  3. Research Specialist2

Offered annual wage, all years, 10th to 90th percentile

Median $47,258; middle half $44,096 to $54,288 · median prevailing wage $47,258 (marker) · 6 applications.

$40k$45k$50k$55k$60k
$40k$45k$50k$55k$60k
Source: U.S. Department of Labor, Office of Foreign Labor Certification — disclosure data FY2008–FY2026 Q3Data as at 30 Jun 2026

H-1B petitions decided by USCIS

Approvals and denials of Form I-129 petitions, by USCIS fiscal year. Linked by employer name, state and the last four digits of the tax ID.

Approved H-1B petitions (initial + continuing)

11FY2018FY2019FY2021
11FY2018FY2019FY2021
Data table
FY20181
FY20191
FY20211
Fiscal yearInitial approvalsInitial denialsContinuing approvalsContinuing denials
FY20210010
FY20191000
FY20180010
Source: U.S. Citizenship and Immigration Services — H-1B Employer Data Hub (FY2009–FY2023)Data as at 30 Jun 2026

Law firms on the filings

Firms named as the employer's representative (firm names only).

Applications by law firm
  1. Kempster, Corcoran, Quiceno & Lenz-Calvo, Ltd2
Source: U.S. Department of Labor, Office of Foreign Labor Certification — disclosure data FY2008–FY2026 Q3Data as at 30 Jun 2026

Among employers in Illinois

Celltrans Inc has 7 work visa applications on record (FY2017–FY2026), ranking #4,670 of 7,029 sponsoring employers in Illinois and #107,451 of 168,030 in the United States; that is 0.00% of the applications filed by employers based in Illinois.

Rank in Illinois
4,670 of 7,029
Rank in the United States
107,451 of 168,030
Share of Illinois's applications
0.00%
Employers in the same industry group (NAICS 541) in Illinois
2,737
Largest sponsoring employers in Illinois
  1. Accenture LLP80,805
  2. Capgemini America Inc60,859
  3. JPMORGAN Chase & Co.45,147
  4. University of Illinois7,712
  5. Capgemini Financial Services USA Inc7,300
  6. Yash Technologies, Inc.5,426
  7. Northwestern University5,294
  8. The University of Chicago5,250
  9. Caterpillar Inc.5,182
  10. Capgemini U.S. LLC5,047
Source: U.S. Department of Labor, Office of Foreign Labor Certification — disclosure data FY2008–FY2026 Q3Data as at 30 Jun 2026

Official data, not advice. Visa Atlas publishes figures from government registers and statistics. It does not assess eligibility or give immigration advice; for advice, consult a regulated adviser. Read more